Label: CYSTEX- methenamine, sodium salicylate tablet
- NDC Code(s): 69693-518-24, 69693-518-48
- Packager: Clarion Brands, LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 26, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purposes
- Uses
- INDICATIONS & USAGE
-
Warnings
Reye's syndrome:Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Stomach bleeding warning:This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding. The chance is higher if you
- are 60 or older
- have stomach ulcers or bleeding problems
- take a blood thinning (anticoagulant) or steroid drug
- take other drugs containing an NSAID (aspirin, ibuprofen, naproxen, or others)
- have 3 or more alcoholic drinks every day while using this product
- take more or for a longer time than directed
- Do not use
- Ask a doctor before use if you are
- Ask a doctor or pharmacist before use if you are
- When using this product
- Stop use and ask a doctor if
-
PREGNANCY OR BREAST FEEDING
If pregnant or breast feeding ask a health professional before use. It is especially important not to use this product (sodium salicylate) during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
- KEEP OUT OF REACH OF CHILDREN
- Directions
- Other information
- Inactive ingredients
-
PRINCIPAL DISPLAY PANEL
DUAL ACTION
Cystex ®
Urinary Health
Methenamine 162 mg | Sodium Salicylate 162.5 mg (NSAID)
PAIN RELIEF (NSAID)
+ UTI BACTERIA CONTROL
2-in-1 Formula to Help Slow UTI Bacteria
Growth and Provice General Pain Relief
Helps Control
UTI infection
Formulated for no
Urine Discoloration
#1 Ingredient for UTI BACTERIAL
Control*
Cystex is not intended to replace a doctor's care.
24 Tablets
TAMPER EVIDENT: TABLETS SEALED IN BLISTER. DO NOT USE IF BLISTER IS OPENED OR DAMAGED.
Distributed by: Cystex, LLC 811 Broad Street
Suite 600, Chattanooga, TN 37402 ©2024
Call 844-297-8394 or visit Cystex.com
*Source: IRI Sales Data, 2023.
Does not contain urine coloring agents as
found in other leading UTI products
1000288
Made In India
RA/Drug/RAJ.-1750
48 tablets
1000273
-
INGREDIENTS AND APPEARANCE
CYSTEX
methenamine, sodium salicylate tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:69693-518 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength METHENAMINE (UNII: J50OIX95QV) (METHENAMINE - UNII:J50OIX95QV) METHENAMINE 162 mg SODIUM SALICYLATE (UNII: WIQ1H85SYP) (SALICYLIC ACID - UNII:O414PZ4LPZ) SODIUM SALICYLATE 162.5 mg Inactive Ingredients Ingredient Name Strength BENZOIC ACID (UNII: 8SKN0B0MIM) POWDERED CELLULOSE (UNII: SMD1X3XO9M) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) FD&C RED NO. 40 (UNII: WZB9127XOA) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER (UNII: NX76LV5T8J) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) TRIETHYL CITRATE (UNII: 8Z96QXD6UM) Product Characteristics Color red Score no score Shape ROUND Size 10mm Flavor Imprint Code CYSTEX Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:69693-518-24 1 in 1 CARTON 11/01/2024 1 24 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:69693-518-48 1 in 1 CARTON 11/01/2024 2 48 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug 505G(a)(3) 11/01/2024 Labeler - Clarion Brands, LLC (079742703)
